Leave questions in the past.

Get answers as to why response to infliximab or adalimumab may be lost.

PROMETHEUS® Anser® ADA
Measures both serum adalimumab (ADA) levels and antibodies to adalimumab.

Learn more 

PROMETHEUS® Anser® IFX
Measures both serum infliximab (IFX) levels and antibodies to infliximab.

Learn more 

NEW PROMETHEUS® Anser® UST
Measures serum ustekinumab (UST) levels and antibodies to ustekinumab.

Learn more 

PROMETHEUS® Anser® VDZ
Measures serum vedolizumab (VDZ) levels and antibodies to vedolizumab.


Learn more 

 

Valuable information to help guide your treatment decisions for patients currently on adalimumab, infliximab, infliximab biosimilar, vedolizumab, or ustekinumab.


This material is provided for general information purposes only, as an educational service for healthcare physicians and their patients. It is not intended as a substitute for medical advice and/or consultation with a physician.

 
PROMETHEUS, the link design, For the person in every patient, Anser, and the Anser design mark are registered trademarks of Prometheus Laboratories Inc, San Diego, California.

©2019 Prometheus Laboratories Inc, San Diego, California. All rights reserved. 07/19

Prometheus tests are laboratory-developed tests that were developed and validated under Federal CLIA laboratory guidelines, and are performed exclusively by Prometheus Laboratories Inc.